Fisher Asset Management LLC lowered its position in shares of Stryker Corporation (NYSE:SYK – Free Report) by 4.4% in the third quarter, Holdings Channel reports. The institutional investor owned 378,378 shares of the medical technology company’s stock after selling 17,396 shares during the period. Fisher Asset Management LLC’s holdings in Stryker were worth $104,202,000 as of its most recent filing with the SEC.
Other institutional investors also recently modified their holdings of the company. International Assets Investment Management LLC boosted its stake in shares of Stryker by 1,432.8% in the third quarter. International Assets Investment Management LLC now owns 25,000 shares of the medical technology company’s stock valued at $6,885,000 after buying an additional 23,369 shares during the period. Amundi increased its stake in Stryker by 18.3% during the 2nd quarter. Amundi now owns 1,246,353 shares of the medical technology company’s stock worth $392,402,000 after acquiring an additional 192,447 shares during the period. The Manufacturers Life Insurance Company increased its stake in Stryker by 8.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 859,544 shares of the medical technology company’s stock worth $270,642,000 after acquiring an additional 65,333 shares during the period. Veritas Asset Management LLP bought a new position in Stryker during the 2nd quarter worth $168,057,000. Finally, Bank of America Corp DE acquired a new position in Stryker in the 2nd quarter valued at $1,404,284,000. Institutional investors own 77.09% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on the company. Robert W. Baird cut their target price on Stryker from $385.00 to $334.00 in a research report on Friday, October 30th. Truist Financial reissued a “hold” rating and set a $305.00 target price (down from $310.00) on shares of Stryker in a report on Monday, November 2nd. BMO Capital Markets restated an “outperform” rating and issued a $309.00 price target (down from $317.00) on shares of Stryker in a research report on Friday, October 30th. Rothschild & Co Redburn dropped their price target on Stryker from $360.00 to $336.00 in a research note on Monday, November 2nd. Finally, JPMorgan Chase & Co. cut their price objective on shares of Stryker from $350.00 to $340.00 and set an “overweight” rating for the company in a research report on Friday, October 30th. Twenty-one research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $342.19.
View Our Latest Stock Analysis on SYK
Stryker Trading Down 0.2%
NYSE SYK opened at $309.05 on Monday. The company has a market cap of $117.65 billion, a price-to-earnings ratio of 32.91, a price-to-earnings-growth ratio of 2.13 and a beta of 0.78. Stryker Corporation has a twelve month low of $267.00 and a twelve month high of $389.33. The company has a quick ratio of 1.30, a current ratio of 2.18 and a debt-to-equity ratio of 0.60. The business’s fifty day moving average is $292.30 and its 200 day moving average is $322.60.
Stryker (NYSE:SYK – Get Free Report) last issued its earnings results on Thursday, October 29th. The medical technology company reported $3.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.55 by ($0.03). The firm had revenue of $6.52 billion during the quarter, compared to analyst estimates of $6.62 billion. Stryker had a return on equity of 23.74% and a net margin of 13.78%. Stryker’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same period in the previous year, the company earned $3.19 EPS. As a group, sell-side analysts expect that Stryker Corporation will post 14.85 EPS for the current fiscal year.
Insider Transactions at Stryker
In other Stryker news, insider Debra King sold 826 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total transaction of $277,783.80. Following the sale, the insider directly owned 6,210 shares of the company’s stock, valued at $2,088,423. The trade was a 11.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Dylan Crotty sold 441 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $328.61, for a total transaction of $144,917.01. Following the completion of the transaction, the insider owned 6,102 shares of the company’s stock, valued at approximately $2,005,178.22. This trade represents a 6.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 901,267 shares of company stock worth $297,123,701. Insiders own 4.60% of the company’s stock.
Stryker Profile
Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings. The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.
Recommended Stories
- Five stocks we like better than Stryker
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.
